The United States has been using various satellite states like Ukraine since 2004 to conduct bioweapons research, often contracting with private companies for the dirty work. Please note the following is from a report of findings issued by the Russian Ministry of Defense. After analyzing the recovered documents they released the following briefing that I’ve edited. Bold emphasis mine.
April 14, 2021
A special military operation by Russian troops has yielded additional information on US military and biological activities in Ukraine, confirming numerous violations of the Biological Weapons Convention.
Taking advantage of existing gaps in international law and the lack of a clear verification mechanism, the US administration has consistently built up its military-biological capabilities in various regions of the world.
The Russian Federation has made continuous efforts to establish a BTWC verification mechanism, but this initiative has been consistently blocked by the collective West, led by the US, since 2001.
The existing UN Secretary-General’s Mechanism to Investigate the Suspected Use of Biological and Toxin Weapons, as well as the 1925 Geneva Protocol for the Prohibition of the Use of Asphyxiating, Poisonous or Other Gases and Bacteriological Methods of Warfare and Military Conflict, do not cover the verification of States Parties’ biological activities.
We have previously provided a scheme for the US coordination of biological laboratories and research institutes in Ukraine.
One of its elements is the Ukrainian Science and Technology Centre (STCU), a seemingly non-public organization that has nothing to do with the Pentagon.
Its legal status is defined by the Agreement of October 25, 1993, between the governments of Ukraine, Canada, the USA, and Sweden and the Protocol of Amendment of July 7, 1997.
STCU is headquartered in Kiev and has regional offices in Baku, Chisinau and Tbilisi, as well as in Kharkov and Lvov.
However, the Russian Ministry of Defence’s Chemical and Biological Threat Expertise Centre found that the STCU’s main activity is to act as a distribution center for grants for research of interest to the Pentagon, including biological weapons research.
In recent years alone, Washington has spent more than $350 million on STCU projects.
The U.S. customers and sponsors of STCU are the Department of State and the Department of Defense. Funding is also provided through the Environmental Protection Agency, the US Departments of Agriculture, Health and Energy.
Between 2014 and 2022, the Ukrainian Science and Technology Centre implemented five hundred R&D projects in post-Soviet countries (Ukraine, Georgia, Moldova and Azerbaijan).
Many of them are aimed at studying potential biological weapons agents (plague, tularaemia) and pathogens of economic importance (pathogenic avian influenza, African swine fever).
Our concern about Washington’s activities in Ukraine stems from the fact that, contrary to its international obligations, the US has retained norms in its national legislation that allow for work in the field of biological weapons.
